Clinical Trial Update: Evaluation of the Inflammation-based Index as a Predictive Marker of Clinical and Radiological Response in Patients Treated With Lu-177 Oxodotreotide for Intestinal Neuroendocrine Tumour [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating an inflammation-based index as a predictor of clinical and radiological response in patients with intest…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intestinal Neuroendocrine Tumor

Drugs mentioned

• LUTATHERA (Lutetium Lu-177 dotatate)

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Intestinal Neuroendocrine Tumor | NA | Status: RECRUITING